ArticleJAMA network open2021

Characteristics of Cost-effectiveness Studies for Oncology Drugs Approved in the United States From 2015-2020.

Alyson Haslam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.